Objective: The aim of this study was to use wound swabs to determine antibiotic resistance patterns in Pseudomonas aeruginosa, which has been shown to be highly resistant to many commonly used antibiotics.
INTRODUCTION
Gram-negative bacteria such as Pseudomonas Aeruginosa (PA) are significant causes of hospital infections and sepsis. It is often seen in epidemics and represents a therapeutic problem faced by physicians because of the development of resistance to many antibiotics which hinders their eradication (1) .
Risk factors for the colonization of a wound or infection that are observed during many epidemics caused by this bacteria include: the presence of an intravascular catheter that can lead to sepsis as a result of the colonization of the skin, emergency abdominal surgery ( gastrointestinal colonization ), length of stay in the hospital or intensive care unit ( mainly the bacteria found in the seriously ill person in the intensive care unit or in the chronically ill patients with a long hospital stay), the severity of the disease, previous stay in an old age home, the presence of urinary catheters, assisted breathing machines and prior therapy with antibiotics (2). Previous literature usually refers to the use of cephalosporins of the III generation, fluoroquinolones, cotrimoxazole, aminoglycosides and penems in order to treat such infections (3) PA has been shown to possess a variety of antibiotic resistant properties which render this dangerous for the patient and can pose difficulties for the physician since such infections can be difficult to treat, especially in a patient with many co-morbidities and serious illness. PA has shown antibiotic resistance by utilizing many mechanisms. These include efflux pumps, decreased permeability of cellular envelopes, hyper mutation, production of antibiotic inactivating enzymes such as β-lactamases like PER-1, PER-2, VEB-1, AmpC cephalosporinases, carbapenemases like serine oxacillinases, metallo-b-lactamases, OXA-type carbapenemases and aminoglycoside-modifying enzymes (4).
The strains of bacteria producing these enzymes can clonally expand in the patient and transmit a particular type of resistance to other bacteria in the same or other bacterial 
SUBJECTS AND METHODS
This study observed 27 isolates of the gram-negative bacteria Pseudomonas aeruginosa and tested their resistance to various commonly used antibiotics. The strains were isolated from wounds of surgical patients of both sexes and different age groups. Patients were hospitalized in various departments (Department of Internal Medicine, Pediatrics, Dermatology, Ear, Nose and Throat, Neurology, Orthopedics, Oncology, and Physical and Rehabilitation medicine).
RESULTS
In 92% (25 patients) out of the total 27 samples, P. Aeruginosa was shown to have a resistance to imipenem and meropenem. 81% of the samples were resistant to ciprofloxacin, 78% to gentamicin, 67% to netilmicin, 55% to piperacillin, 48% to piperacillin/tazobactam ceftazidime, 41% to cefepime, 37% to aztreonam, 22% to tobramicin and 11% to amikacin.
Resistance to colistin was not documented.
Therefore, according to the resistance patterns we see that the most effective antibiotic for PA infection in our sample population was colistin (100% sensitivity), followed by Antibiotic Resistance Patterns of Pseudomonas aeruginosa 4 amikacin (88% sensitivity), tobramicin (81% sensitivity). The least effective antibiotics were found to be carbapenems (8% sensitivity) and ciprofloxacin (12% sensitivity).
DISCUSSION
Pseudomonas aeruginosa is known to be a cause of skin and subcutaneous infections. Often these include post-operative infections in surgical wounds, burn victims and in chronic skin conditions (6, 7, 8) . According to certain liturature, PA is the 4th most common cause of surgical wound infections (9). One of the most worrisome characteristics of PA is its low antibiotic susceptibility, which is the result of the action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes such as mexAB and mexXY. Another mechanism of antibiotic resistance is the low permeability of the bacterial cellular envelopes although Campylobacter is showing resistance to these antibiotics as well (17) .
Antibiotics should only be used when needed as prescribed by health professionals (18). The prescriber should closely adhere to the five rights of drug administration: the right patient, the right drug, the right dose, the right route, and the right time (19) . Narrowspectrum antibiotics are preferred over broad-spectrum antibiotics when possible, as effectively and accurately targeting specific organisms is less likely to cause resistnace (20) .
Cultures should be taken before treatment when indicated and the treatment potentially changed based on the susceptibility report (21, 22) . For patients who take these medications without the supervision of a medical professional at home, education on proper use is imperative since non compliance is a major risk in the development of antibiotic resistant bacterial strains. Health care providers can also use a few simple steps to decrease the spread of multiresistant bacteria. These include proper and frequent handwashing and disinfecting between patients; and they should encourage the same to the patient, visitors, and family members (21) .
CONCLUSION
The isolates of Pseudomonas aeruginosa show a high degree of resistance (>50% resistance)
to commonly used antibiotics such as imipenem and meropenem, ciprofloxacin, gentamicin, netilmicin and piperacillin. It is therefore imperative that the physician take this into account Wound infections caused by multi-drug resistant bacteria are a major therapeutic challenge for physicians and healthcare workers worldwide and should be dealt with appropriately in hopes to avoid further patient morbidity, decreasing hospital stay and ensuring the best care
and management for the patient.
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